Skip to content
PubMed This is a summary of 50 peer-reviewed journal articles Updated
Neurology

Ataxia with Vitamin E Deficiency (AVED): A Patient Guide

At a Glance

Ataxia with Vitamin E Deficiency (AVED) is a genetic disorder caused by faulty vitamin E transport. Early, consistent high-dose vitamin E can stabilize symptoms or slow progression, but treatment must continue lifelong with specialist monitoring.

Ataxia with Vitamin E Deficiency (AVED) is an ultra-rare genetic disorder that fundamentally changes how the body protects its nervous system. In a healthy body, vitamin E acts as a critical shield, neutralizing the “oxidative stress” that would otherwise damage delicate nerve cells. However, for those living with AVED, a mutation in the TTPA gene breaks the internal transport system responsible for packaging vitamin E and circulating it through the bloodstream [1]. Without this protective delivery, the nerves in the spinal cord and the cerebellum—the brain’s coordination center—slowly begin to wear down, leading to progressive challenges with balance, speech, and movement [2].

On the surface, AVED is often indistinguishable from other more common conditions, most notably Friedreich’s Ataxia (FRDA). Both disorders present with a similar clinical signature of unsteadiness, loss of reflexes, and coordination issues, which frequently leads to initial misdiagnosis [3]. Yet, despite these outward similarities, the biological cause of AVED is entirely unique. While many genetic ataxias are caused by complex cellular energy failures or protein misfolding, AVED is essentially a localized deficiency: the body is capable of absorbing vitamin E from food but is genetically unable to retain or distribute it to the tissues that need it most [4].

This specific biological mechanism is the reason AVED is often called a “treatable ataxia.” While the condition is progressive and potentially disabling if left alone, the core message for every patient and family is one of significant hope. By providing the body with high-dose vitamin E supplements, we can bypass the broken transport protein and supply the system with the vitamin it needs [5]. When started early and maintained consistently, this treatment often has the ability to stabilize or substantially slow the progression of the disease [6].

Living with AVED requires a commitment to lifelong care and vigilant monitoring. Because the body’s transport system remains defective, treatment must be uninterrupted to prevent further nerve damage. This journey involves not just daily supplementation, but also a dedicated team of specialists to monitor eye health, bone alignment, and physical strength. While a diagnosis of a rare genetic condition is life-changing, AVED is a rare instance where medical science offers a clear path forward, helping to manage a progressive condition [7].

Common questions in this guide

What causes Ataxia with Vitamin E Deficiency (AVED)?
AVED is caused by a mutation, or change, in the TTPA gene. This change disrupts the system that packages and transports vitamin E, so the body can absorb vitamin E from food but cannot properly retain or deliver it to nerve tissues.
Why can AVED be mistaken for Friedreich ataxia?
Both conditions can cause unsteadiness, loss of reflexes, and coordination problems, so they may look similar at first. AVED has a TTPA-related vitamin E transport problem, which distinguishes it biologically from Friedreich ataxia.
Can high-dose vitamin E treat AVED?
Yes. High-dose vitamin E supplements can bypass the defective transport system and may stabilize symptoms or substantially slow progression, especially when treatment starts early and is taken consistently. Because the transport defect remains, treatment needs to continue lifelong and should not be interrupted without medical guidance.
What symptoms can AVED cause?
AVED can progressively affect balance, speech, coordination, and movement. People may also have unsteadiness and loss of reflexes, and the condition can become disabling without treatment.
How is AVED monitored during treatment?
Ongoing care includes checking whether vitamin E treatment is effective and monitoring neurological function. Specialists may also follow blood vitamin E levels, eye health, bone alignment, and physical strength; the treating team decides how often each check is needed.
Which specialists may help care for someone with AVED?
Care may involve genetic counselors and physical therapists, along with specialists who monitor neurological function, eye health, bone alignment, and strength. The exact care team can be tailored to the patient's symptoms, mobility, and independence goals.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How soon can we begin high-dose vitamin E treatment now that the diagnosis is confirmed?
  2. 2.What specific neurological symptoms do you expect will stabilize with consistent treatment?
  3. 3.Are there other specialists, such as genetic counselors or physical therapists, who should join our care team immediately?
  4. 4.How often will we need to check blood levels to ensure the treatment is effective?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    α-Tocopherol transfer protein (α-TTP).

    Arai H, Kono N

    Free radical biology & medicine 2021; (176()):162-175 doi:10.1016/j.freeradbiomed.2021.09.021.

    PMID: 34563650
  2. 2

    The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons.

    Ulatowski L, Ghelfi M, West R, et al.

    The Journal of biological chemistry 2022; (298(3)):101712 doi:10.1016/j.jbc.2022.101712.

    PMID: 35150738
  3. 3

    A first description of ataxia with vitamin E deficiency associated with MT-TG gene mutation.

    Maalej M, Kammoun F, Kharrat M, et al.

    Acta neurologica Belgica 2021; (121(6)):1733-1740 doi:10.1007/s13760-020-01490-4.

    PMID: 32979145
  4. 4

    Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein.

    Chung S, Ghelfi M, Atkinson J, et al.

    The Journal of biological chemistry 2016; (291(33)):17028-39 doi:10.1074/jbc.M116.734210.

    PMID: 27307040
  5. 5

    First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy.

    Kohlschütter A, Finckh B, Nickel M, et al.

    Neuro-degenerative diseases 2020; (20(1)):35-38 doi:10.1159/000508080.

    PMID: 32623435
  6. 6

    Ataxia With Vitamin E Deficiency Syndrome and a Novel TTPA Variant: A Paired Case Report.

    Baso G, Magri F, Sciacco M, et al.

    Neurology. Genetics 2026; (12(3)):e200399 doi:10.1212/NXG.0000000000200399.

    PMID: 42164107
  7. 7

    Ataxia with vitamin E deficiency in the Philippines : A case report of two siblings.

    Tabuena MD, Morigaki R, Miyamoto R, et al.

    The journal of medical investigation : JMI 2021; (68(3.4)):400-403 doi:10.2152/jmi.68.400.

    PMID: 34759169

This page is for informational purposes only and does not constitute medical advice about AVED. Your neurology and genetics team should determine vitamin E dosing, monitoring, and other care for your specific situation.

Get notified when new evidence is published on Ataxia with vitamin E deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.